1. CXCL14 is a natural inhibitor of the CXCL12–CXCR4 signaling axis. Issue 12 (11th May 2013) Authors: Tanegashima, Kosuke; Suzuki, Kenji; Nakayama, Yuki; Tsuji, Kohei; Shigenaga, Akira; Otaka, Akira; Hara, Takahiko Journal: FEBS letters Issue: Volume 587:Issue 12(2013) Page Start: 1731 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dimeric peptides of the C‐terminal region of CXCL14 function as CXCL12 inhibitors. Issue 23 (23rd October 2013) Authors: Tanegashima, Kosuke; Tsuji, Kohei; Suzuki, Kenji; Shigenaga, Akira; Otaka, Akira; Hara, Takahiko Journal: FEBS letters Issue: Volume 587:Issue 23(2013) Page Start: 3770 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficient one-pot synthesis of CXCL14 and its derivative using an N-sulfanylethylanilide peptide as a peptide thioester equivalent and their biological evaluation. Issue 17 (1st September 2015) Authors: Tsuji, Kohei; Tanegashima, Kosuke; Sato, Kohei; Sakamoto, Ken; Shigenaga, Akira; Inokuma, Tsubasa; Hara, Takahiko; Otaka, Akira Journal: Bioorganic & medicinal chemistry Issue: Volume 23:Issue 17(2015) Page Start: 5909 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Epigenetic regulation of the glucose transporter gene Slc2a1 by β‐hydroxybutyrate underlies preferential glucose supply to the brain of fasted mice. (9th December 2016) Authors: Tanegashima, Kosuke; Sato‐Miyata, Yukiko; Funakoshi, Masabumi; Nishito, Yasumasa; Aigaki, Toshiro; Hara, Takahiko Journal: Genes to cells Issue: Volume 22:Number 1(2017) Page Start: 71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗